Skip to main content

The Cardiovascular Disease Fellowship program at the University of Maryland has risen to premier status in recent years. We are indebted to our expert faculty, alumni, community of colleagues, and our trainees for their dedication to excellence in cardiovascular care and education.

The Division of Cardiovascular Medicine is a robust practice, including 30 full-time faculty as well as several adjunct faculty, specializing in the areas of preventative cardiology, non-invasive imaging, heart failure and transplant, pulmonary hypertension, interventional cardiology, electrophysiology, advanced imaging and adult congenital heart disease. Clinical services are supported at the University of Maryland Medical Center, Baltimore VA Medical Center, and outreach practices in Westminster, Owings Mills, and Waterloo in Maryland. The division works in close collaboration with the Divisions of Cardio-Thoracic Surgery, Vascular Surgery, Pediatric Cardiology and Radiology.

The fully equipped Cardiology Ambulatory Care Center (CAC) was opened in 2005 and supports a robust outpatient practice and is the site of Fellow continuity and cardiomyopathy clinics. In-patients are cared for in a 15-bed Coronary Care Unit and a 14-bed Progressive Care Unit, with an additional 11-bed telemetry unit on the 3rd floor.

The division operates 3 university cardiac catheterization laboratories with a 4th, state-of-the-art hybrid-lab under construction, 2 electrophysiological laboratories and 1 VA cardiac catheterization laboratory which is also planned for state-of-the art renovation in the 2019-2020 academic year. Our Echocardiography lab performs more than 14,000 studies yearly, including 3-D imaging and assisting on structural cases for MitraClip and Watchman.

Our electrophysiology (EP) services are distinguished by their unique focus on real time scar and site imaging using PET-CT during ablative procedures. A robotic catheter guidance system is also employed to provide more accurate ablative interventions for ventricular and atrial arrhythmias. The interventional cardiology (IC) section supports a robust program in complex coronary intervention, including CTO, as well as structural interventions including TAVR, Mitra-Clip, and percutaneous atrial and ventricular septal defect closures. Additionally, the IC section has developed a program in advanced approaches to mechanical circulatory support including axillary access and septostomy to support patients on ECMO. A collaborative EP/IC/Imaging program evaluates patients for left atrial appendage closure devices.

The clinical program in heart failure, transplantation, and pulmonary hypertension is one of the largest and most successful in the country with internationally recognized faculty in the field with 15-20 orthotopic heart transplants and over 40 VAD implants annually.

The division has highly active clinical, basic science and translational research platforms with distinction in the areas of lipid research, heart failure research, genomic and proteomic biomarker medicine, pharmacogenomics and cardiomyocyte biology. In the 2019-2020 academic year, 2 ABIM Research pathway Fellows joined our program and will be mentored in a physician scientist track.

We are most proud of our rigorous fellowship training program, recruiting highly motivated and clinically adept Fellows with an aptitude for scholarly productivity. In the past 5 trainee cycles, graduates have pursued careers in academic cardiology or further sub-specialization in the areas of EP, IC and advanced imaging. Through financial donations of our engaged Alumni, Fellows have been able to attend and present at national and international forums. Fellows have also been productive of publications in high-impact peer-reviewed journals. Further our Fellows have been recipients of departmental teaching awards, nursing-colleague awards and ACGME sponsored Back to the Bedside Grant Awards.

We are grateful to our community of colleagues, our alumni network, and our fellows for propelling us to these heights.

Sincerely,

Mukta C Srivastava, MD
Program Director, Cardiovascular Disease Fellowship Program
Assistant Professor of Medicine, University of Maryland School of Medicine